Alkyl-conjugated SHPs exhibit inhibition activity against acetylcholinesterase (AChE) and butyrylcholinesterase in combination with antioxidant properties, which allowed them to be considered as candidates for drugs against Alzheimer’s disease. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.